35 related articles for article (PubMed ID: 22014034)
1. The Q
Wall RJ; Carvalho S; Milne R; Bueren-Calabuig JA; Moniz S; Cantizani-Perez J; MacLean L; Kessler A; Cotillo I; Sastry L; Manthri S; Patterson S; Zuccotto F; Thompson S; Martin J; Marco M; Miles TJ; De Rycker M; Thomas MG; Fairlamb AH; Gilbert IH; Wyllie S
ACS Infect Dis; 2020 Mar; 6(3):515-528. PubMed ID: 31967783
[TBL] [Abstract][Full Text] [Related]
2. Investigation into in silico and in vitro approaches for inhibitors targeting MCM10 in Leishmania donovani: a comprehensive study.
Saha S; Sharma A; Bhowmik D; Kumar D
Mol Divers; 2024 May; ():. PubMed ID: 38722455
[TBL] [Abstract][Full Text] [Related]
3. Novel mycosin protease MycP₁ inhibitors identified by virtual screening and 4D fingerprints.
Hamza A; Wagner JM; Evans TJ; Frasinyuk MS; Kwiatkowski S; Zhan CG; Watt DS; Korotkov KV
J Chem Inf Model; 2014 Apr; 54(4):1166-73. PubMed ID: 24628123
[TBL] [Abstract][Full Text] [Related]
4. Current leishmaniasis drug discovery.
Pinheiro AC; de Souza MVN
RSC Med Chem; 2022 Sep; 13(9):1029-1043. PubMed ID: 36324493
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis reveals allelic variation and chromosome copy number variation in paromomycin-resistant Leishmania donovani.
Ghosh S; Kumar V; Verma A; Sharma T; Pradhan D; Selvapandiyan A; Salotra P; Singh R
Parasitol Res; 2022 Nov; 121(11):3121-3132. PubMed ID: 36056959
[TBL] [Abstract][Full Text] [Related]
6.
Ramalingam K; Gangwar S; Balodi DC; Anand A; Yadav S; Biswas S; Karunakaran Sasikala AK; Gupta KC; Batra S; Goyal N
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0236121. PubMed ID: 35852367
[TBL] [Abstract][Full Text] [Related]
7. Antileishmanial assessment of isoxazole derivatives against
Mukhopadhyay S; Barak DS; Karthik R; Verma SK; Bhatta RS; Goyal N; Batra S
RSC Med Chem; 2020 Sep; 11(9):1053-1062. PubMed ID: 33479698
[TBL] [Abstract][Full Text] [Related]
8. Computational approaches for drug discovery against trypanosomatid-caused diseases.
Pereira CA; Sayé M; Reigada C; Silber AM; Labadie GR; Miranda MR; Valera-Vera E
Parasitology; 2020 May; 147(6):611-633. PubMed ID: 32046803
[TBL] [Abstract][Full Text] [Related]
9. Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds.
Ravinder ; Bhaskar ; Gangwar S; Goyal N
Curr Microbiol; 2012 Dec; 65(6):696-700. PubMed ID: 22945482
[TBL] [Abstract][Full Text] [Related]
10. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
11. Structure- and Ligand-Based Approaches to Evaluate Aporphynic Alkaloids from Annonaceae as Multi-Target Agent Against Leishmania donovani.
Lorenzo VP; Lúcio AS; Scotti L; Tavares JF; Filho JM; Lima TK; Rocha JD; Scotti MT
Curr Pharm Des; 2016; 22(34):5196-5203. PubMed ID: 27174814
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel inhibitors of dipeptidylcarboxypeptidase of Leishmania donovani via ligand-based virtual screening and biological evaluation.
Gangwar S; Baig MS; Shah P; Biswas S; Batra S; Siddiqi MI; Goyal N
Chem Biol Drug Des; 2012 Feb; 79(2):149-56. PubMed ID: 22014034
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M
J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575
[TBL] [Abstract][Full Text] [Related]
14. Novel approaches for the identification of inhibitors of leishmanial dipeptidylcarboxypeptidase.
Goyal N
Expert Opin Drug Discov; 2013 Sep; 8(9):1127-34. PubMed ID: 23745836
[TBL] [Abstract][Full Text] [Related]
15. The discovery of novel β-secretase inhibitors: pharmacophore modeling, virtual screening, and docking studies.
Niu Y; Ma C; Jin H; Xu F; Gao H; Liu P; Li Y; Wang C; Yang G; Xu P
Chem Biol Drug Des; 2012 Jun; 79(6):972-80. PubMed ID: 22381116
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
